LeanLife Health Inc. to benefit from Safe Food for Canadians Regulations
19 Décembre 2018 - 3:30PM
LeanLife Health Inc. (“LeanLife”) (CSE: LLP) will benefit from new
food safety measures.
Recently, the Canadian Minister of Health and
the Minister of Agriculture announced the launch of an online
method to allow for licence applications under the Safe Food for
Canadians Regulations.
While Canada is recognized as having one of the
strongest food safety systems in the world the Safe Food for
Canadians Regulations will make this system even
safer. LeanLife will benefit from the consolidation of these
regulations and the new application method as it prepares to export
its Omega-3 flaxseed oil product across Canada and around the
world.
LeanLife will also benefit from an exemption
from the United States Foreign Supplier Verification Program. This
Program places restrictions on U.S. food importers accept where
food products are intended for further manufacturing by a U.S.
processor. As LeanLife's product is a fortified food ingredient
with a long-lasting shelf life it is an ideal additive for the
purpose of enriching a variety of foods with Omega-3 essential
fatty acids.
"In general, these consolidated regulations will
make it easier for LeanLife Health to export. We therefore see this
as a positive development for LeanLife to get its product to the
United States, Europe or elsewhere", said Stan Lis, Chief Executive
Officer of LeanLife Health.
About LeanLife Health and the Omega-3
Market
LeanLife Health’s products are extracted from
flax seeds, a plentiful and non-animal source of Omega-3. The
products can be used as a food additive or as a nutraceutical and
have been used to make bread, noodles, cheese, yogurt, juice and
milk products for the European market. LeanLife Health’s industry
leading Omega-3 product formulations are of the highest quality and
contain no cholesterol. Products are available in oil, emulsion and
powder forms.
The global Omega-3 market is expected to reach
USD $7.32 billion by 2020, according to a report by Grand View
Research, Inc.
For more information, please contact:
Stan Lis, CEO604-764-0518SLis@LeanLifeHealth.com
Forward Looking
InformationInformation set forth in this news release
contains forward-looking statements that are based on assumptions
as of the date of this news release. These statements reflect
management's current estimates, beliefs, intentions and
expectations. They are not guarantees of future performance. The
Company cautions that all forward looking statements are inherently
uncertain and that actual performance may be affected by a number
of material factors, many of which are beyond the Company's control
including, the Company's ability to compete with large food
companies; sales of any potential products developed will be
profitable; the ability to complete sales under the sales
agreement. Accordingly, actual and future events, conditions and
results may differ materially from the estimates, beliefs,
intentions and expectations expressed or implied in the
forward-looking information. Except as required under applicable
securities legislation, the Company undertakes no obligation to
publicly update or revise forward-looking information.
THE CSE HAS NEITHER APPROVED NOR
DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE
LeanLife Health (CSE:LLP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
LeanLife Health (CSE:LLP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024